600161 logo

Beijing Tiantan Biological Products Co., Ltd. Stock Price

SHSE:600161 Community·CN¥30.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

600161 Share Price Performance

CN¥15.58
-4.29 (-21.59%)
CN¥15.58
-4.29 (-21.59%)
Price CN¥15.58

600161 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and fair value.

2 Risks
4 Rewards

Beijing Tiantan Biological Products Co., Ltd. Key Details

CN¥6.4b

Revenue

CN¥3.4b

Cost of Revenue

CN¥3.0b

Gross Profit

CN¥1.7b

Other Expenses

CN¥1.3b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 28, 2026
0.67
46.63%
20.49%
1.0%
View Full Analysis

About 600161

Founded
1966
Employees
5298
CEO
Yanlin He
WebsiteView website
www.tiantanbio.com

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.

Recent 600161 News & Updates

Recent updates

No updates